DPP4 and type 2 diabetes mellitus: The purpose of the present study is, therefore, to examine the efficacy of DPP-4 inhibitors when given as add-on therapy to the combination of metformin and sulphonylurea in patients with type 2 diabetes and suboptimal glycaemic control.